Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Refractory Hepatic Hydrothorax: A Rare Complication of Systemic Sclerosis and Presinusoidal Portal Hypertension.
Case Reports Hepatol
April 2018
Department of Pathology, Greenville Health System, University of South Carolina School of Medicine Greenville, Greenville, SC, USA.
We report on a rare case of refractory hepatic hydrothorax in an individual with Scleroderma/CREST syndrome and noncirrhotic portal hypertension. Portal pressure measurements revealed a normal transjugular hepatic venous portal pressure gradient, mild pulmonary hypertension, and an unremarkable liver biopsy except for mild sinusoidal dilation. Pulmonary hypertension, cardiac diastolic dysfunction, and chronic kidney disease were determined to be the causes of his refractory pleural effusions and ascites.
View Article and Find Full Text PDFCutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome.
Eur J Rheumatol
December 2017
Department of Internal Medicine, Ufuk University School of Medicine, Ankara, Turkey.
Upper gastrointestinal bleeding (watermelon stomach) in a patient with limited scleroderma (CREST syndrome).
Reumatol Clin
July 2018
Servicio de ESI-Reumatología, Departamento de Medicina Especialidades Médicas, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España.
Osteonecrosis of multiple joints in a patient with limited scleroderma/CREST syndrome.
J Clin Rheumatol
April 2015
VA Medical Center, Wilkes Barre, Pennsylvania
Pulsed versus continuous wave low-level light therapy on osteoarticular signs and symptoms in limited scleroderma (CREST syndrome): a case report.
J Biomed Opt
January 2015
RoseLab Skin Optics Laboratory, 3333 100th Avenue, Suite 200, Laval, Quebec, H7T 0G3, Canada.
Limited cutaneous systemic sclerosis (lcSSc) was formerly known as CREST syndrome in reference to the associated clinical features: calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasias. The transforming growth factor beta has been identified as a major player in the pathogenic process, where low-level light therapy (LLLT) has been shown to modulate this cytokine superfamily. This case study was conducted to assess the efficacy of 940 nm using millisecond pulsing and continuous wave (CW) modes on osteoarticular signs and symptoms associated with lcSSc.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!